Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

13.9K
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or...
13.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Hoechst Reporter Enables Visualization of Drug Engagement <i>In Vitro</i> and <i>In Vivo</i>: Toward Safe and Effective Nanodrug Delivery.

ACS nano·2022
Same author

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance.

Communications biology·2021
Same author

Correction: Upregulation of annexin A1 protein expression in the intratumoral vasculature of human non-small-cell lung carcinoma and rodent tumor models.

PloS one·2021
Same author

Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR.

Molecular cancer therapeutics·2021
Same author

Long-acting antibody ligand mimetics for HER4-selective agonism.

Scientific reports·2020
Same author

Metabolite-Based Modification of Poly(l-lysine) for Improved Gene Delivery.

Biomacromolecules·2020

Related Experiment Video

Updated: Apr 21, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

8.9K

Bi-epitope SPR surfaces: a solution to develop robust immunoassays.

Li Peng1, Melissa M Damschroder1, Herren Wu1

  • 1Department of Antibody Discovery and Protein Engineering, MedImmune, One MedImmune Way, Gaithersburg, MD, 20878, United States of America.

Plos One
|November 6, 2014
PubMed
Summary
This summary is machine-generated.

Researchers developed a rapid method to enhance low-affinity antibodies for surface plasmon resonance (SPR) immunoassays. This bi-epitope surface approach significantly improves binding affinity and detection sensitivity for target molecules like human ephrin type A receptor 2 (EphA2).

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.5K
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

6.1K

Related Experiment Videos

Last Updated: Apr 21, 2026

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

8.9K
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

14.5K
Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays
10:44

Snap Chip for Cross-reactivity-free and Spotter-free Multiplexed Sandwich Immunoassays

Published on: November 13, 2017

6.1K

Area of Science:

  • Biochemistry
  • Immunotechnology
  • Surface Chemistry

Background:

  • Surface plasmon resonance (SPR) immunoassays are crucial for sensitive detection but depend on high-affinity reagents.
  • Low-affinity antibodies often limit the sensitivity and reliability of SPR-based assays.
  • Developing efficient methods to enhance antibody performance is essential for advancing SPR applications.

Purpose of the Study:

  • To present a rapid method for converting low-affinity antibodies into effective capture reagents for SPR immunoassays.
  • To investigate the efficacy of 'bi-epitope' sensor surfaces compared to 'single-epitope' surfaces in enhancing binding affinity and detection sensitivity.
  • To demonstrate the application of this method using antibodies against human ephrin type A receptor 2 (EphA2).

Main Methods:

  • Generation of 'bi-epitope' sensor surfaces by co-immobilizing pairs of anti-EphA2 antibodies via standard amine coupling.
  • Comparison of apparent binding affinities and detection sensitivities between bi-epitope and single-epitope surfaces using a ProteOn XPR36 system.
  • Characterization of binding kinetics, including affinity and dissociation rates, for both surface types.

Main Results:

  • Bi-epitope surfaces demonstrated a 10-100 fold improvement in apparent binding affinities compared to single-epitope surfaces across all tested antibody pairs.
  • For low-affinity antibodies, bi-epitope surfaces improved apparent binding affinity to approximately 10(-10) M and dissociation rates to 10(-4) s(-1).
  • This resulted in a 100-200 fold enhancement in the limit of detection for EphA2 in crude cell supernatants.

Conclusions:

  • The co-immobilization of antibody mixtures to create bi-epitope surfaces is a powerful strategy for developing sensitive SPR immunoassays.
  • This approach effectively enhances the performance of low-affinity antibodies, overcoming limitations in SPR-based detection.
  • The method offers a promising avenue for accelerating the development and application of SPR assays in various fields.